疫苗注射设备市场规模、份额和成长分析（按设备类型、给药途径、最终用户和地区）- 2025-2032 年产业预测

2023 年疫苗输送装置市场规模价值 67.7 亿美元，预计将从 2024 年的 73.3 亿美元成长到 2032 年的 138.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.3%。

受疫苗接种倡议不断增加和对高效给药方法的需求的推动，全球疫苗输送设备市场正在经历强劲增长。主要驱动因素包括疫苗接种计划的扩大、针头技术的进步以及预防保健意识的增强。这凸显了可靠低温运输的重要性，尤其是在缺乏足够冷藏设施的地区。自动停用针筒和预填充式注射器系统等输送装置的最新创新提高了安全性和有效性。目前，北美和欧洲引领市场，但亚太地区具有巨大的成长潜力。随着疫苗需求的激增，市场将朝着创新、易于使用且具成本效益的输送解决方案的方向发展。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析
• 技术分析

疫苗注射设备市场规模（按设备类型和复合年增长率） (2025-2032)

• 市场概况
• 无针注射系统
• 口服给药系统
• 鼻腔给药系统
• 喷射注射器
• 微针贴片
• 微量注射器

疫苗注射装置市场规模（按註射途径和复合年增长率） (2025-2032)

• 市场概况
• 皮内接种
• 肌肉注射
• 皮下接种
• 其他疫苗接种

疫苗注射装置市场规模（按最终用户和复合年增长率划分）（2025-2032 年）

• 市场概况
• 医院
• 诊所
• 其他最终用户

疫苗注射装置市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Becton Dickinson & Company（USA）
• Bioject Medical Technologies, Inc.（USA）
• Inovio Pharmaceuticals, Inc.（USA）
• PharmaJet（USA）
• Vaxxas（Australia）
• Gerresheimer AG（Germany）
• SCHOTT AG（Germany）
• Corium International, Inc.（USA）
• 3M（USA）
• West Pharmaceutical Services, Inc.（USA）
• Terumo Corporation（Japan）
• B. Braun Melsungen AG（Germany）
• Smiths Medical（UK）
• Medtronic（Ireland）
• Sanofi Pasteur（France）
• Novartis AG（Switzerland）
• Pfizer Inc.（USA）
• GlaxoSmithKline plc（UK）
• Merck & Co., Inc.（USA）
• Johnson & Johnson（USA）

结论和建议

Vaccine Delivery Devices Market size was valued at USD 6.77 billion in 2023 and is poised to grow from USD 7.33 billion in 2024 to USD 13.88 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global vaccine delivery devices market is experiencing robust growth, fueled by increased vaccination initiatives and the demand for efficient administration methods. Key drivers include the expansion of immunization programs, advancements in needle technology, and heightened awareness of preventive healthcare. A crucial concern remains the integrity of vaccines during storage and transport, emphasizing the importance of a reliable cold chain, particularly in areas lacking proper refrigeration. Recent innovations in delivery devices, including auto-disable syringes and prefilled syringe systems, enhance safety and efficacy. While North America and Europe currently lead the market, the Asia-Pacific region shows significant growth potential. As vaccine demand surges, the market is poised for evolution with an emphasis on innovative, user-friendly, and cost-effective delivery solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vaccine Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vaccine Delivery Devices Market Segments Analysis

Global Vaccine Delivery Devices Market is segmented by Type of Device, Route of Administration, End Users and region. Based on Type of Device, the market is segmented into Needle-Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches and Microinjectors. Based on Route of Administration, the market is segmented into Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination and Other Vaccinations. Based on End Users, the market is segmented into Hospitals, Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vaccine Delivery Devices Market

The increasing demand for vaccines, fueled by continuous initiatives aimed at tackling infectious diseases like COVID-19 and various preventable illnesses, has created a significant driver for the vaccine delivery devices market. As global health efforts intensify, the necessity for efficient and reliable delivery systems becomes paramount to guarantee proper immunization. This surge in vaccine production and distribution emphasizes the critical role that advanced delivery devices play in enhancing vaccination rates and ensuring the effectiveness of immunization programs. Consequently, the growth of the vaccine delivery devices market is closely linked to the rising urgency for innovative solutions that meet the needs of public health initiatives.

Restraints in the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market faces significant constraints due to the high costs associated with developing and manufacturing advanced technologies. The extensive research and development required can lead to substantial expenses, which are often transferred to end-users such as healthcare facilities and patients. This financial burden can hinder the widespread adoption of these innovative devices, especially in resource-limited environments. Consequently, the cost-related barriers may restrict access in certain regions, preventing the full realization of the benefits that these advanced vaccine delivery solutions can offer in enhancing immunization efforts and overall public health outcomes.

Market Trends of the Vaccine Delivery Devices Market

The Vaccine Delivery Devices market is witnessing a notable trend towards innovations in needle-free delivery systems, which are rapidly gaining traction among healthcare providers and patients alike. These advanced technologies, including jet injectors, microneedle patches, and nasal sprays, address common concerns associated with traditional needle-based vaccinations, such as anxiety and needle-stick injuries. By offering alternative delivery methods, these innovations not only enhance patient compliance but also improve vaccine stability and efficacy. As vaccination campaigns become increasingly critical, the shift towards needle-free solutions is expected to drive market growth, enhance operational efficiencies, and transform the overall vaccination experience.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Vaccine Delivery Devices Market Size by Type of Device & CAGR (2025-2032)

• Market Overview
• Needle-Free Injection Systems
• Oral Delivery Systems
• Nasal Delivery Systems
• Jet Injectors
• Microneedle Patches
• Microinjectors

Global Vaccine Delivery Devices Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Other Vaccinations

Global Vaccine Delivery Devices Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Other End Users

Global Vaccine Delivery Devices Market Size & CAGR (2025-2032)

• North America (Type of Device, Route of Administration, End Users)
  • US
  • Canada
• Europe (Type of Device, Route of Administration, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Device, Route of Administration, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Device, Route of Administration, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Device, Route of Administration, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton Dickinson & Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxas (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corium International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations